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Erika López-Arribillaga1,*, Verónica Rodilla1,*, Luca Pellegrinet2, Jordi Guiu1, Mar Iglesias3,
Angel Carlos Roman4, Susana Gutarra5, Susana González6, Pura Muñoz-Cánoves5,7,
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ABSTRACT
Genetic data indicate that abrogation of Notch-Rbpj or Wnt-β-catenin
pathways results in the loss of the intestinal stem cells (ISCs).
However, whether the effect of Notch is direct or due to the aberrant
differentiation of the transit-amplifying cells into post-mitotic goblet
cells is unknown. To address this issue,we havegenerated composite
tamoxifen-inducible intestine-specific genetic mouse models and
analyzed the expression of intestinal differentiation markers.
Importantly, we found that activation of β-catenin partially rescues
the differentiation phenotype ofRbpj deletionmutants, but not the loss
of the ISC compartment. Moreover, we identified Bmi1, which is
expressed in the ISC and progenitor compartments, as a gene that is
co-regulated byNotch and β-catenin. Loss ofBmi1 resulted in reduced
proliferation in the ISC compartment accompanied by p16INK4a and
p19ARF (splice variants of Cdkn2a) accumulation, and increased
differentiation to the post-mitotic goblet cell lineage that partially
mimics Notch loss-of-function defects. Finally, we provide evidence
that Bmi1 contributes to ISC self-renewal.
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INTRODUCTION
The intestinal epithelium constitutes an excellent system for
studying stem cell function. Intestinal stem cells (ISCs) reside at
the bottom of intestinal crypts, where they are maintained in a
multipotent and self-renewing state. ISCs are the source of a transit-
amplifying compartment, which undergoes ∼4-5 rounds of rapid
cell division (Marshman et al., 2002) before achieving the
terminally differentiated state. Then, the resulting differentiated
enterocytes, goblet cells and enteroendocrine cells move towards
the tip of the villi in a process that takes around 2-4 days, whereas a
fourth differentiated cell type, the Paneth cells, migrate downwards
to the crypt basewhere they reside for 6-8 weeks (van der Flier et al.,
2009). Long-term lineage tracing has identified Lgr5, Bmi1, Tert
and Hopx (Barker et al., 2007; Montgomery et al., 2011; Sangiorgi
and Capecchi, 2008; Schepers et al., 2011; Takeda et al., 2011; Tian
et al., 2011) as ISC markers. However, it is plausible that different
levels of these markers identify specific ISC subpopulations
(Itzkovitz et al., 2012).
Notch and Wnt-β-catenin pathways are essential regulators of
normal stem cells in multiple tissues, including the intestine (Ireland
et al., 2004; Korinek et al., 1998; Pellegrinet et al., 2011; Riccio
et al., 2008), and several examples of co-regulatory crosstalk have
been described (Espinosa et al., 2003; Estrach et al., 2006; Hayward
et al., 2005; Kwon et al., 2011; Rodilla et al., 2009). Notch signaling
is activated by specific ligands that are present in neighboring cells,
whereas β-catenin activation relies on the presence of soluble Wnt
ligands (reviewed in Bigas et al., 2013). By using lineage-tracing
analysis, it has recently been proven that Notch1 and Notch2 are
specifically expressed (Fre et al., 2011) and required (Riccio et al.,
2008) to maintain homeostasis in the intestinal crypt, with the
Paneth cells being responsible for producingWnt and Notch signals
(Sato et al., 2011). Complete inhibition of Notch signaling in the
intestinal epithelium results in the loss of the proliferative crypt
compartment and the loss of the conversion of crypt progenitors into
the post-mitotic secretory lineages (van Es et al., 2005), partially
overlapping with the phenotype that is obtained after deletion of the
Notch target gene Hes1 (Jensen et al., 2000). The molecular basis
for the differentiation-associated defects is the overexpression of
Math1, a master regulator of the absorptive intestinal lineage, which
is repressed by Hes1. Nevertheless, genetic inactivation of Hes1 or
knockout (KO) of Hes1, Hes3 and Hes5 simultaneously in the adult
mouse intestine leads to reduced cell proliferation and increased
secretory cell formation but does not affect ISC integrity (Ueo
et al., 2012).
Bmi1 is a member of the Polycomb group of transcriptional
repressors, the function of which in the intestine is unknown. Bmi1 is
an essential regulator of hematopoietic, neural and lung epithelial
stem cells, mainly through repression of the cell cycle regulators
p16INK4a and p19ARF (splice variants encoded by Cdkn2a – Mouse
Genome Informatics) (Bruggeman et al., 2005;Molofsky et al., 2005;
Oguro et al., 2006; Zacharek et al., 2011). Deletion of both p16INK4a
and p19ARF genes substantially restores the self-renewal capacity of
Bmi1−/− hematopoietic stem cells (HSCs) (Oguro et al., 2006),
whereas increased p16INK4a levels that are found in old mice induce
an aging-associated decrease in HSC self-renewal (Janzen et al.,
2006). Interestingly, Bmi1 null mice do not show any evident
developmental defect, but they die prematurely (around 2-3 months),
which is associated with a progressive decrease in the number of
hematopoietic cells and with different neurological abnormalities. In
the intestine, Bmi1 was initially detected in label-retaining stem cells
located at the +4 position from the bottom of the crypt. This label-
retaining feature might indicate a quiescent nature or the capacity to
asymmetrically segregate DNA strands (Li and Clevers, 2010; Potten
et al., 2002). However, we and others (Munoz et al., 2012)Received 2 January 2014; Accepted 28 October 2014
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demonstrate that Bmi1 expression is unrestricted throughout the crypt
compartment, similar to that of other proposed stem cell markers,
such as Hopx and Tert.
We find here that Bmi1 is a downstream effector of Notch in the
ISC and progenitor compartment and that Bmi1 is involved in ISC
self-renewal.
RESULTS
Notch and Wnt pathways are simultaneously required to
maintain the intestinal stem cell compartment in vivo
We first investigated the relative contribution of Notch to the ISC
compartment using a combination of gain- and loss-of-function (GOF
and LOF, respectively) mutants that had been previously developed.
Specifically, we used a tamoxifen-inducible Cre recombinase driven
by the villin promoter (Villin-CreER-T2) to conditionally deleteRbpj in
the intestinal epithelium, which we combined with the active form of
β-catenin (Ctnnb1lox(ex3)). We have previously demonstrated that
genetic depletion of Notch signaling results in the complete loss of
ISC markers and the intestinal stem cell function (Pellegrinet et al.,
2011; Riccio et al., 2008). We have now confirmed this Notch-
dependent ISC phenotype and found that it was not rescued byectopic
activation of the β-catenin pathway using Rbpjlox;Ctnnb1lox(ex3) mice
(Fig. 1A,B; supplementarymaterial Fig. S1). Consequently, all single
and double mutants died around day 5-6 after the first tamoxifen
injection. As a control, constitutive activation of β-catenin alone led
to the expansion of the undifferentiated crypt compartment, which
was accompanied by ectopic expression of Olfm4, Lgr5 and Ascl2.
Immunohistochemistry (IHC) analysis of these mice further
confirmed that post-mitotic goblet cells (Fig. 1C) accumulate in the
intestinal crypts of Rbpj-depleted mice, which was associated with a
profound reduction of the proliferative compartment, as shown by the
small number of Ki67-positive cells. Interestingly, in the intestinal
crypts of the composite Rbpjlox;Ctnnb1lox(ex3) mutants, both the
differentiation to goblet cells imposed by Rbpj (Notch) LOF, and
Fig. 1. Notch and β-catenin are both
required for maintaining intestinal
homeostasis in vivo. (A) In situ hybridization
(ISH) of different stem cell markers on
intestinal sections from the indicated mouse
genotypes in the Villin-CreER-T2 background,
4 days after treatment with tamoxifen. Insets
show enlarged images of the boxed areas.
(B) Quantification of the expression levels of
the indicated genes by qRT-PCR analysis
from isolated intestinal crypts, normalized
against Villin expression. (C) Anti-Ki67 IHC
and Alcian Blue staining of goblet cells on
intestinal crypts of the indicated genotypes.
(D,E) Quantification of the number of goblet
(D) and Ki67-positive cells (E) per crypt unit in
more than 40 crypts counted per genotype.
For Alcian Blue staining, nuclei were
counterstained with Fast Red dye.
Ctnnb1active corresponds to the β-catenin
GOF mutant Ctnnb1 lox(ex3) and Rbpj lox to the
Notch LOF mutant. ICN1 corresponds to the
inducible Notch1 GOF mutant ICN1LSL. In
C-E, error bars represent the s.d., and
statistical significance was determined using
Student’s t-test. *P<0.05, **P<0.01 and
***P<0.001. H&E, hematoxylin and eosin
staining.
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the reduction in the number of proliferating ISCs and progenitor
cellswere significantly rescued, leading tovalues comparable to those
of the wild-type (WT) intestine, although reduced compared with the
single β-catenin GOF (Fig. 1C-E).
These results indicate that β-catenin activation partially
compensates the effect of Rbpj (Notch) LOF in goblet cell
differentiation without rescuing the loss of the ISC compartment.
Transcriptional activation of theBmi1gene is downstreamof
Notch and β-catenin
To better understand the requirement for Notch in the ISC
compartment, we explored a previously identified transcriptional
gene signature that is simultaneously dependent on Notch and
β-catenin in colorectal cancer cells (Rodilla et al., 2009). The ISC-
related gene PCGF4/Bmi1 was included in this signature as it was
downregulated following β-catenin or Notch inhibition, but failed to
be induced by active Notch1 (intracellular fragment of Notch1,
ICN1) in the absence of β-catenin signaling. By contrast, the
canonical Notch target gene Hes1 was found to be strictly
dependent on ICN1 in intestinal cancer cells (Fig. 2A). Using the
Genomatix software, we identified several adjacent TCF- and Rbpj-
binding consensus sequences in the regulatory region of the murine
Bmi1 gene that were functionally validated in purified murine crypt
cells by sequential chromatin immunoprecipitation (ChIP) assay. In
particular, the recruitment of Notch and β-catenin proteins was
detected in a predicted region close to the transcriptional start site
that contained both consensus binding sequences (Fig. 2B, pp2
region; supplementary material Fig. S2A). Next, we tested whether
Bmi1 transcription required Notch and β-catenin activities in the
normal intestinal crypt cells. By using IHC, we found that Bmi1
Fig. 2. Notch and β-catenin are simultaneously required to activate Bmi1. (A) Gene expression of Bmi1 and Hes1 in Ls174T/dnTCF4 cells treated for 48 h
with doxycyline (to induce dnTCF4 and inhibit β-catenin signaling) or DAPT (Notch and γ-secretase inhibitor) or both, compared with untreated cells. Expression
levels were determined by using qRT-PCR analysis normalizing against the β-actin gene. (B) Sequential ChIP analysis of the Bmi1 promoter with the indicated
antibodies. Chromatin was isolated from intestinal crypts. Black squares show the relative position of primers in the promoter scheme. (C) IHC (left) and qRT-PCR
(right) analyses of Bmi1 in intestinal tissue from the indicated mouse genotypes in the Villin-CreER-T2 background, 4 days after treatment with tamoxifen.
Ctnnb1active corresponds to the β-catenin GOFmutantCtnnb1lox(ex3) andRbpjlox to the Notch LOFmutant. ICN1 corresponds to the inducible Notch1 GOFmutant
ICN1LSL. Insets show enlarged images of the boxed areas. (D) Total cell extracts from isolated crypts were precipitated using the anti-β-catenin antibody.
Precipitates were analyzed by western blotting for the presence of active Notch. (E,F)Bmi1 reporter assays to test the effect of the indicated constructs. Increasing
amounts of ICN1, MaM1 and β-catenin constructs were transfected. Dominant-negative (dn)Rbpj and dnTCF4 were used to inhibit Notch and β-catenin,
respectively. (G) Molecular model of the regulation of the Bmi1 promoter by Notch, β-catenin and Hes1. The graph shows the hypothetical Bmi1 expression levels
in the presence (red) or absence (black) of Hes1, when both the Notch and Wnt-β-catenin pathways are active. In E and F, error bars represent the s.d., and
statistical significance was determined using Student’s t-test. *P<0.05, **P<0.01 and ***P<0.001. IP, immunoprecipitation; Maml, Mastermind-like; mBmi1,
mouse Bmi1, N1, Notch1; n.s., not significant; pro, promoter; pp, primer pair; sh-Hes1, small hairpin.
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expression was mainly restricted to the intestinal epithelial crypt
cells of WT mice (Fig. 2C), where activation of both pathways
occurs (Sato et al., 2011). Importantly, specific Rbpj deletion
resulted in the total loss of Bmi1 expression in these cells (data not
shown) that was not recovered by the constitutive activation of the
β-catenin pathway (Fig. 2C). However, β-catenin was also essential
to maintain Bmi1 expression even in the presence of active Notch1
(Fig. 2C). By co-precipitation of protein extracts from purified
intestinal crypts, we demonstrated that endogenous β-catenin
and active Notch1 physically interact in this tissue (Fig. 2D),
further supporting the notion of their functional interplay. Next, we
generated a reporter construct carrying 2.5 kb of the proximal Bmi1
promoter, including the putative Rbpj and TCF consensus sites,
fused to the luciferase gene (supplementary material Fig. S2B).
We found that pharmacological inhibition of Notch or β-catenin
pathways (by using DAPT or PKF115-584, respectively)
(supplementary material Fig. S2C), or the ectopic expression of
dominant-negative forms ofRBPJ andTCF4 (supplementarymaterial
Fig. S2D), were sufficient to repress transcription driven by the Bmi1
promoter. Conversely, the Notch coactivator Mastermind (MaM)
induced this construct in an RBPJ- and TCF4-dependent manner
(Fig. 2E), although neither Notch nor β-catenin alone could induce
Bmi1-driven transcription, suggesting that MaMwas a limiting factor
in these cells. By contrast, transcriptional repression through the
specific Notch target Hes1 protein is a widely used mechanism for
attenuating Notch-dependent transcription (Krejci et al., 2009). We
found several Hes consensus binding sites in the Bmi1 promoter
(supplementary material Fig. S2B) that we functionally tested in the
reporter experiments. Ectopic Hes1 expression totally abolished Bmi1
transcription, whereas knockdown of Hes1 increased Bmi1 reporter
activityand facilitated its activation through ICN1,β-catenin andMaM
(Fig. 2F). Our results indicate that Bmi1 transcription is positively
regulated by Notch, β-catenin and the coactivator MaM, and is
repressed byHes1 (Fig. 2G), which fine-tunesBmi1 levels in response
to Notch activation (see Discussion).
By interrogating the whole human and mouse genomes for the
frequency of contiguous Rbpj- and TCF-binding consensus
sequences, we found that both sequences were not randomly
distributed but that they clustered in the promoter region of multiple
genes close to their transcription start sites (supplementary material
Fig. S2E). Rbpj-binding consensus siteswere significantly enriched at
distances of 100-200 bp, 300-400 bp and 700-800 bp from the TCF-
binding consensus (supplementarymaterial Fig. S2F), comparedwith
not only 1000 randomly permuted site distributions (P<0.001) but
also with the 500 bp neighborhood of the observed data (P=0.001 for
100-200 bp and 300-400 bp;P=0.002 for 700-800 bp), indicative of a
conserved mechanism for Notch and Wnt co-regulation.
Bmi1-deficient mice display intestinal defects that resemble
a Notch LOF phenotype
Bmi1 protein is detected in different intestinal crypt cells, including
the long-term ISC population (Sangiorgi and Capecchi, 2008);
however, the functional significanceofBmi1 in intestinal homeostasis
has not been addressed. Bmi1-deficient mice are born at Mendelian
ratios but die prematurely (around 2-3 months of age), presenting
growth retardation and stem cell-associated defects (Bruggeman et al.,
2005; Molofsky et al., 2005; Oguro et al., 2006). We analyzed the
intestine of Bmi1 KO mice at 2-3 months of age and found that the
small intestinewas significantly shorter (35.88±2.3 cm in theWTand
28.33±2.5 cm in the KO, P<0.001) (Fig. 3A) and thinner (Fig. 3B)
compared with that ofWT littermates, and a similar length defect was
found in the colon (7.05±1.0 cm in theWTand 5.5±1.2 cm in theKO,
P=0.04) (Fig. 3A). Through IHC analysis of Ki67 expression and
Alcian Blue staining (Fig. 3C,D), as well as the use of a 5-bromo-2′-
deoxyuridine (BrdU) proliferation assay (supplementarymaterial Fig.
S3A), we observed that Bmi1 mutants display a significant reduction
in the number of cycling crypt cells in both the small intestine and the
colon.This observationwas associatedwith amoderate but significant
increase in goblet cell differentiation, partially resembling the
phenotype obtained upon Rbpj (Notch) deficiency. Double staining
for BrdU and the ISC marker Olfm4 demonstrated that proliferation
defects involved both the ISC (3.1±2.2 BrdU and Olfm4 double-
positive cells in the WT compared with 1.0±1.6 in the KO; P<0.001)
and, to a minor extent, the transit-amplifying compartment (6.9±3.4
BrdU-positive cells in the WT compared with 6.3±3.6 in the KO,
P=0.17) (Fig. 3E). Comparable results were obtained through the
analysis of the cell cycle profile of intestinal crypt populations
expressing different levels of the surface marker Ephb2; ISCs were
included in the Ephb2high population, and most of the transit-
amplifying cells were included in the Ephb2medium population (Jung
et al., 2011) (Fig. 3F). The intestinal phenotype of Bmi1-deficient
micewas not exclusive of adult animals, but it was already detectable
at day 3 after birth (supplementary material Fig. S3B,C), indicating
that it originates during development. Consistent with the alterations
of the colonic tissue, Bmi1 protein was also detected in cells located
at the bottom of the WT colonic crypts (supplementary material
Fig. S3D), which has not been reported previously.
Next, we determined the expression levels of different stem
cell markers in the intestinal crypts of Bmi1-deficient mice. Using
IHC and quantitative reverse-transcriptase (qRT) PCR analyses, we
did not find any significant change in the expression levels of the
Lgr5, Olfm4, Ephb2, c-Myc, Hopx and Lrig1 genes in the Bmi1-
deficient intestines (Fig. 3G,H). However, Tert, recently identified
as a marker for slow-cycling intestinal stem cells in mice, was
significantly downregulated in the Bmi1-deficient crypt cells
(Fig. 3H), which could indicate altered long-term self-renewal.
Bmi1 or Notch deficiency results in increased expression of
the cell cycle regulators p16INK4a and p19ARF
Because most of the stem cell defects that have been previously
identified in the Bmi1 KO mice are associated with upregulation of
p16INK4a and p19ARF, which are targets of Bmi1 repression, we next
determined their levels in the intestinal crypts of our different
mutant mice. By using IHC (Fig. 4A,C) and qRT-PCR (Fig. 4D)
analyses, we found that p16INK4a and p19ARF levels were
significantly increased in the absence of Bmi1, which might
account for the observed decrease in ISC proliferation. Similarly,
the number of intestinal p16INK4a-positive cells was significantly
increased in the absence of Rbpj, both in the single LOF and the
composite β-catenin GOF and Rbpj LOF mutants (Fig. 4B,C). By
contrast, the highly proliferative Ctnnb1lox(ex3) transgenic intestines
did not show any increase in p16INK4a expression. These results
strongly suggest that Bmi1, downstream of Notch and β-catenin,
contributes to the regulation of ISC and progenitor proliferation
either directly or through p16INK4a and p19ARF.
Because Bmi1 protein is involved in the regulation of the stem cell
compartments in other tissues, including the blood, we considered the
possibility that the intestinal defects observed in the general Bmi1-
deficientmicewere of systemic origin (instead of tissue autonomous).
To test this, we generated a Villin-Cre;Bmi1lox/lox line in which the
Bmi1 gene was specifically deleted in the intestinal epithelium
(although more efficiently in the duodenum than in the distal ileum
and colon, data not shown). IHC analysis of 3- to 4-week-old
intestinal-specific Bmi1KOmice showed a consistent and significant
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accumulation of p16INK4a-positive cells along the whole crypt-villus
axis, which was associated with a reduction in the number of
proliferatingKi67-positive cells when comparedwith that of theirWT
littermates (Fig. 4E). However, we did not detect a consistent
reduction in the size of the tissue-specific KO intestines when
compared with those found in the conventional Bmi1 null mice.
In agreement with the possibility that intestinal defects that are
associated with Bmi1 deficiency originate during embryonic
development, we found a massive increase in p16INK4a levels and
a reduction in the number of Ki67-positive cells in the embryonic
intestine at the time of villus formation (embryonic days 15 and 16)
(Fig. 4E; supplementary material Fig. S3E).
The Bmi1-deficient phenotype mimics that of Notch
inhibition with respect to the self-renewal and DNA repair
capacity of ISCs
We performed serial culture assays of intestinal organoids (Sato
et al., 2009) to further study the requirement of Bmi1 in ISC
function. Intestinal organoids are derived from ISC and can be
maintained indefinitely after serial passaging.We found that serially
replated organoids (after passage 10) contain a high number of
Bmi1-expressing cells (Fig. 5A, right panels), which was reduced
following Notch inhibition by using DAPT (Fig. 5A,B). This was
before the failure of organoid growth that occurred at around 3-4
days of treatment with DAPT (Fig. 5A, left panels). Interestingly,
Notch inhibition in these cultures led to the transcriptional
activation of p16INK4a and p19ARF (Fig. 5C) that was concomitant
with a reduction in the mRNA levels of Olfm4 and Ascl2
(supplementary material Fig. S4A).
We next isolated intestinal crypt cells from Bmi1-deficient mice to
measure their clonogenic capacity. Bmi1-deficient crypt cells
generated organoids at a similar efficiency to their WT counterparts,
but their replating capacity gradually declined from passage 5-7, and
they failed to grow after passage 15-16 (Fig. 5D; supplementary
material Fig. S4B). Associated with their defective long-term self-
renewal, mutant organoids at passage 12-15 contained a significant
Fig. 3. Bmi1-deficient mice display
intestinal abnormalities that partially
overlap with the effects of Notch
deficiency. (A) Photograph of
intestines from 2-month-old mice of the
indicated genotypes and sex.
(B) Quantification of the crypt-villus axis
length in the intestines of WT and Bmi1
KO mice. (C) IHC analysis showing
Ki67-positive proliferating cells and
Alcian Blue-stained goblet cells in the
duodenum and colon of the indicated
genotypes. (D) Quantification of the
number of proliferating cells and goblet
cells in the different regions of the
intestine of Bmi1 WT or KO mice,
compared with those of the Rbpj-
deficient animals (a minimum of 50
crypts per region were counted in each
case). Note the slight variability found in
the WT animals from different genetic
backgrounds. (E) Detection of BrdU-
positive cells (2 h after BrdU injection)
in the ISC compartment, identified by
the expression of Olfm4 through ISH
analysis. The average number and s.d.
of double-positive cells per crypt, from
30 crypts counted for each genotype, is
indicated. (F) Cell cycle profile of the
Ephb2high and Ephb2medium intestinal
cell populations from WT and Bmi1 KO
animals. One representative from two
independent experiments is shown.
(G) ISH analysis of the indicated ISC
genes in Bmi1 WT or KO mice.
(H) Quantification by using qRT-PCR
analysis of the mRNA levels in the crypt
fractions. In B, D and H, error bars
represent the s.d., and statistical
significance was determined using
Student’s t-test. *P<0.05, **P<0.01 and
***P<0.001. n.s., not significant.
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number of terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL)-positive cells in the epithelial layer thatweremostly
negative for active caspase3 staining (Fig. 5E), suggesting that Bmi1
deficiency favors the accumulation of DNA breaks independently of
apoptosis. To validate this finding, we determined the DNA repair
capacity of Bmi1-deficient intestinal cells in response to γ-irradiation
in vivo. With this aim, we irradiated Bmi1WT or KO littermates with
12 Gy, whichwere then killed 2 h later and processed for IHC analysis
with an antibody against γH2A.X. We found that WT intestines
specifically accumulate γH2A.X staining in the villus regions,which is
an indication of unrepaired DNA breaks. However, intestinal crypt
cells only showed discrete γH2A.X foci as a result of efficient DNA
repair, as previously published (Hua et al., 2012). By contrast, Bmi1-
deficient intestines displayed an intense homogeneous γH2A.X
staining pattern arising from the base of the crypts to the top of the
villi (Fig. 5F), indicating that Bmi1 protein is involved in regulating
DNAdamage repair in the intestinal crypt cells. This is consistent with
the known role of Bmi1 protein in DNA damage repair through H2A
monoubiquitylation, which facilitates the recruitment of the repair
machinery (Ginjala et al., 2011; Ismail et al., 2010; Pan et al., 2011).
Taken together, our results indicate that Notch signaling exerts a
direct effect on the maintenance of ISCs that involves a direct
cooperation with β-catenin at the chromatin level to regulate gene
transcription. We identify Bmi1 as target of both Notch and
β-catenin and demonstrate that intestinal Bmi1 deficiency results in
reduced proliferation and limited self-renewal of the ISCs (see
model in Fig. 5G).
DISCUSSION
We have identified a new mechanism for gene regulation that
depends on the simultaneous activity of two crucial signaling
pathways, Wnt-β-catenin and Notch, and is functional in the normal
Fig. 4. Increased p16INK4a in the intestine of
Bmi1-deficient or Rbpj-deficient mutants.
(A) IHC analyses showing p16INK4a levels and
distribution in the intestine of Bmi1WTand KO
mouse. (B) IHC showing p16INK4a levels and
distribution in the intestine of the indicated
mouse genotypes. (C) Quantification of the
number of cells per intestinal crypt displaying
nuclear p16INK4a staining. In B and C,
Ctnnb1active corresponds to the β-catenin GOF
mutant Ctnnb1lox(ex3) and Rbpj lox to the Notch
LOF mutant. (D) Quantification of qRT-PCR
analyses of the p16INK4a and p19ARF mRNA
levels in Bmi1 WT and KO crypt fractions.
Genes for β2 microglobulin, GAPDH and villin
were all used for normalization. (E) IHC
analyses showing p16INK4a and Ki67 levels of
intestinal epithelial-specific Bmi1-deficient
mice. The graph shows the quantification of
Ki67-positive cells per crypt (a minimum of 30
crypts were counted for each sample, n=3).
(F) IHC analyses of p16INK4a, Ki67 and Bmi1
(the latter a control for the lack of protein
expression) in Bmi1 WT and null intestines at
embryonic day (E)15.5. In C-E, error bars
represent the s.d., and statistical significance
was determined using Student’s t-test.
*P<0.05, **P<0.01 and ***P<0.001.
46
RESEARCH ARTICLE Development (2015) 142, 41-50 doi:10.1242/dev.107714
D
E
V
E
LO
P
M
E
N
T
intestinal crypts. Importantly, we have identified Bmi1 as a target of
both β-catenin and Notch, and characterized its function in ISCs.
Accordingly, Bmi1 has been previously identified as a Wnt and
KLF4 target in colorectal cancer cells (Yu et al., 2012). We found
that Bmi1 deficiency only reproduces some of the defects that are
associated with Notch inhibition, including altered proliferation and
increased crypt cell differentiation into secretory cells, indicating
that many other genes downstream of Notch are also required for
ISC function. Moreover, Bmi1 helps to maintain the DNA integrity
and self-renewal capacity of the ISC population in vitro, which
should be further investigated in relation to the Notch pathway.
Wnt and Notch are well-known stem cell regulators in many
different systems, having synergic or antagonistic effects that are
context dependent. In the intestine, both pathways are required to
maintain the undifferentiated compartment (Ireland et al., 2004;
Korinek et al., 1998; Riccio et al., 2008; van Es et al., 2005).
Nevertheless, the contribution of each signal and their orchestration
is still under debate. Our results indicate that both pathways need to
be simultaneously active to maintain the stem cell compartment, but
suggest that this evolutionary strategy might be of general use, as
indicated by the non-random distribution of TCF- and Rbpj-binding
consensus sites along the entire mouse and human genomes. In this
Fig. 5. The Notch inhibition phenotype mimics that of Bmi1 deficiency with respect to the self-renewal and DNA repair capacity of ISCs.
(A) Representative image of vehicle- or DAPT-treated organoid cultures at 72 h (n=3). Right panels show Bmi1 protein in both conditions. (B,C) Expression levels
of Bmi1 p16INK4a and p19ARF as determined by qRT-PCR analyses of organoids treated as indicated. The relative expression was normalized against the
gene encoding β2microglobulin. In all these experiments organoids were grown for 5 days before treatment. A representative of three independent experiments is
shown. (D) The cumulative number of organoids obtained from WT and Bmi1-deficient crypt cells after passage (p)15. One representative of two independent
experiments is shown. (E) Double staining of the cleaved caspase3 and TUNEL assay to determine the amount of apoptosis and DNA damage in WT and
Bmi1 KO organoids at passage 15, representative of three independent experiments. (F) γH2A.X immunofluorescence of Bmi1WT and KO intestines collected
2 h after whole-animal irradiation (12 Gy). (G) Model of Bmi1 regulation by Wnt and Notch signals supplied by adjacent Paneth cells. In B and C, error bars
represent the s.d., and statistical significance was determined using Student’s t-test. *P<0.05, **P<0.01 and ***P<0.001. β-cat, β-catenin; Maml, Mastermind-like;
Ub, ubiquitin.
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work, we focused on studying Bmi1, the expression of which
depends on Notch- and β-catenin-mediated signaling, and we
demonstrate that the Bmi1 promoter is directly regulated by both
factors in association with the MaM coactivator. Conversely, the
Notch target gene Hes1, which is also a master regulator of the
absorptive and secretory lineage differentiation, represses Bmi1,
suggesting that its expression is dynamically regulated in the crypt
through the participation of both positive and negative signals.
Notch has been previously shown to control this type of regulatory
loop, also known as type I incoherent feed-forward loops (I1-IFF) in
Drosophila (Guiu et al., 2013; Krejci et al., 2009).
Although the original identification of Bmi1 as a target of both
Notch and β-catenin was based in the use of cancer cell lines, this
regulation is also found in a physiological context, such as the ISCs.
Bmi1 function was known to be crucial for hematopoietic and
neural stem cells, but its role in the intestine has not been defined
previously. We here show that Bmi1 deletion results in reduced
intestinal size, associated with increased differentiation into goblet
cells and reduced proliferation of the stem cell compartment, a
phenotype that partially overlaps with that produced by the absence
of Notch or Rbpj signaling in the ISC compartment. Although Bmi1
null mice show a decrease in body weight, we cannot exclude that
this is a secondary effect of defective intestinal function. However,
several ISC markers are still detected in the intestine of Bmi1-
deficient animals, and this tissue is maintained for at least 3 months
(the life expectancy of these animals), which is very different from
the strong intestinal phenotype that is associated with complete
Notch and/or β-catenin depletion. This fact reflects the functional
relevance of other Notch and β-catenin targets, such as Ephb2 or
c-Myc in ISC maintenance. Of note, the severity of the Notch
deletion phenotype might vary among different genetic
backgrounds, as reflected by the work of Yin and colleagues (Yin
et al., 2014).
By culturing normal or Bmi1-deficient ISC in Matrigel, we here
demonstrate that intestinal crypt cells from Bmi1-deficient animals
have incomplete self-renewal capacity associated with increased
DNA damage repair, a phenotype that was confirmed in the
irradiated Bmi1-deficient intestines and is in agreement with the
identification of the Bmi1-positive cells as a radio-resistant
population with capacity to replace Lgr5-positive cells after
radiation (Yan et al., 2012). Inhibition of Notch in the organoid
cultures results in Bmi1 downregulation, upregulation of p16INK4a
and p19ARF and a reduced number of Ki67-positive cells, before
terminal organoid differentiation. These results suggest that Bmi1
contributes to proliferation and self-renewal downstream of Notch
and β-catenin, probably by regulating the cell cycle through
p16INK4a and p19ARF, DNA repair (Ismail et al., 2010), telomere
length (Dimri et al., 2002; Jacobs and de Lange, 2004) and
senescence (Park et al., 2004), which are known functions
of Bmi1.
MATERIALS AND METHODS
Animals
All animal work was conducted according to the guidelines fromGeneralitat
de Catalunya, and this study was approved by the committee for animal
experimentation at Institut Hospital del Mar d’Investigacions Med̀iques
(Barcelona, Spain). The mouse transgenic line Villin-CreER-T2 (in the
C57BL/6 background), in which Cre recombinase expression is confined to
the intestinal epithelium, was crossed with the different floxed mice to
generate intestine-specific gene-targeted mice. The CreER-T2 recombinase
activity was induced by injecting 2- to 3-week-old mice with tamoxifen
(10 mg/kg body weight in corn oil; Sigma) intraperitoneally for three
consecutive days. The general Bmi1 null mice were in an FVB/NJ
background. Intestine-specific Bmi1 KO animals were obtained by crossing
the previously described Bmi1lox (Arranz et al., 2012) with the Villin-Cre
(from Jackson Laboratories) line (both in C57BL/6 background). In all the
experiments using Bmi1-deficient mice, animals were euthanized before any
obvious sign of disease was detected.
Cell lines and reagents
Cell lines expressing dominant-negative TCF4 (Ls174T/dnTCF4) and ICN1
(Ls174T/dnTCF4/ICN1) have been previously described (Rodilla et al.,
2009; van de Wetering et al., 2002) and were maintained in Dulbecco’s
media with 10% fetal bovine serum (FBS). Doxycycline (Sigma) was used
at 1 µg/ml. The γ-secretase inhibitor DAPT (Calbiochem) was used at
25 µM.
RT-PCR
Total RNA was extracted with the RNeasy Qiagen kit, and RT-First Strand
cDNA Synthesis kit (Amersham Pharmacia Biotech) was used. The primers
used for RT-PCR analyses are listed in supplementary material Table S1A.
qRT-PCR was performed in a LightCycler480 system using SYBR Green I
Master kit (Roche).
ChIP
Briefly, chromatin from cross-linked cells was sonicated, incubated overnight
with the indicated antibodies in radioimmunoprecipitation assay (RIPA)
buffer and precipitated with protein G/A-Sepharose. Cross-linkage of the co-
precipitated DNA-protein complexes was reversed, and DNA was used as a
template for the PCR. Antibodies against cleaved Notch1 (ab8925, Abcam)
and β-catenin (BDBioscience, catalog no. 61054)were used. For secondChIP
experiments, complexes from the first ChIP were eluted through incubation in
25 μl of 10 mM dithiothreitol for 30 min at 37°C. After centrifugation, the
supernatant was diluted with RIPA buffer and subjected to the ChIP
procedure. The primers used are listed in supplementary material Table S1B.
In situ hybridization (ISH)
Intestinal samples were flushed gently with cold PBS and fixed overnight in
4% paraformaldehyde at room temperature. Samples were then dehydrated,
embedded in paraffin and sectioned at 8 µm. After de-waxing and
rehydration, the samples were treated with 0.2 N HCl and proteinase K
(30 µg/ml). Samples were hybridized for 24 h at 65°C. After washing,
blocking solution was added (blocking reagent, Roche) and incubation with
an antibody against digoxigenin was performed overnight at 4°C. Next
morning, samples were washed and developed with NBT/BCIP (Roche).
The RNA probes were obtained from complementary DNA of mouse
c-Myc, Hes1, Olfm4, Ascl2 and Lgr5, and were generated through in vitro
transcription with a Digoxigenin RNA Labeling Kit (Roche) according to
the manufacturer’s instructions.
Intestinal crypt isolation and organoid culture in Matrigel
Mouse small intestines were collected, sliced longitudinally and thoroughly
washed in cold PBS. Villi were removed by carefully scraping the surface.
Remaining tissue was cut into small sections, treated twice with 2 mM
EDTA for 30 min and centrifuged at 110 g to obtain the crypt-enriched
fraction as previously described (Sato et al., 2009). Approximately 105 cells
were seeded in 50 μl Matrigel (BD Biosciences) in 24-well plates. After
polymerization, 500 μl of complete organoid medium [(DMEM/F12,
Biological Industries) with penicillin (100 U/ml) and streptomycin
(100 μg/ml) (Biological Industries) supplemented with N2 and B27
(Invitrogen) containing 140 nM ROCK inhibitor (Y27632, Sigma),
100 ng/ml Noggin (Peprotech), 100 ng/ml R-spondin (R&D Systems),
50 ng/ml EGF (Sigma) and 20 ng/ml basic FGF (Peprotech)] was added.
Medium was changed every 2 days. Incubator conditions were 37°C,
5% CO2.
Organoid immunostaining
Organoids were collected from Matrigel (BD Bioscience), placed onto a
slide by using cytospin and circled with DakoPen (Dako). Whole-mount
immunostaining was performed after fixation with 4% paraformaldehyde
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and permeabilization with 0.3% Triton X-100 (Pierce). Organoids were
stained with an antibody against γH2A.X (1:200; Cell Signaling, catalog
no. 2577) overnight and then incubated with secondary antibody
donkey-anti-rabbit Alexa Fluor 488 (Molecular Probes) for 2 h at room
temperature at a 1:1000 dilution. Slides were mounted in VectaShield with
DAPI (Vector). Other antibodies used were: anti-Bmi1 (1:100; Abcam,
ab14389), followed by donkey anti-mouse Alexa Fluor 488, and anti-
cleaved caspase3 (1:500; Cell Signaling, catalog no. 9661).
TUNEL assay
The TUNEL assay was performed using the DeadEnd Colorimetric
Apoptosis Detection System (Promega), according to the manufacturer’s
instructions.
Image analysis
IHC of intestinal sections was observed by using an Olympus BX61
microscope, and images were taken using the cellSens Digital Imaging
software. Measurement of intestinal thickness was performed using the
Aperio ImageScope Image Analysis Platform. Immunofluorescence images
of intestinal sections and organoids were taken by using confocal
microscopy with a Leica SP5 TCS upright microscope and the Leica
Application Suite Advanced Fluorescence software.
Immunoprecipitation assays
Purified intestinal murine crypt cells were lysed for 30 min at 4°C in 300 µl
PBS plus 0.5% Triton X-100, 1 mM EDTA, 100 mM sodium
orthovanadate, 0.25 mM PMSF and complete protease inhibitor cocktail
(Roche). Supernatants were pre-cleared for 2 h with 1% bovine serum
albumin (BSA), 1 µg IgGs and 50 µl sepharose protein A (SPA) beads and
incubated overnight with 3 µg of specific anti-β-catenin antibody.
Antibody-protein complexes were then captured with 30 µl SPA beads for
2 h, extensively washed in lysis buffer, and the precipitates were analyzed
by western blotting.
Bioinformatics analysis
The human genome was scanned for the detection of Rbpj-([CG][CT]-
GTGGGAA[AC]) and TCF4- (G[TA][TA]CAA[TA]GGG) binding sites in
both forward or reverse strands using a modified version of a previously
described algorithm (Roman et al., 2008) that identifies local genomic
regions with colocalization of several binding sites. P values were obtained
by the Z-scores derived from observed and permuted distributions of the
binding sites. Graphs and statistics were built with R Statistical package.
Promoter analysis and luciferase assays
The Bmi1-luc reporter was generated by cloning the region from −2009 to
+484 of the human Bmi1 gene into the pGL2 basic vector (Promega), which
was then verified by sequencing. The primers used were GLprimer1 and
GLprimer2 from Promega. Luciferase reporter assays were performed in
HEK-293T cells. Cells were seeded in 12-well plates at a density of 5×104
cells/well. In the different experiments, 250 ng or the indicated amounts of
ICN1,Mastermind, dominant-negative Rbpj, dominant-negative TCF4, small
hairpin RNA against Hes1 (shHes1; MISSION, TRCN0000018989) or
irrelevant DNA, plus 150 ng RSV-β-galactosidase and Bmi1 promoter-
luciferase (Bmipro-luc) plasmids were transfected into triplicate wells using
polyethylenimine (PEI) (Polysciences). Where indicated, HEK-293T cells
were treatedwith γ-secretase inhibitor orDAPT (Calbiochem) at a 50 µM final
concentration for 72 h before transfection and during the assay for 24 h with
the β-catenin inhibitor PKF115584 at 0.66 μM (kindly given by Novartis).
Luciferase activity was measured after 48 h of transfection following the
manufacturer’s instructions (Luciferase Assay System, Promega). Expression
levels of transfected proteins were verified by western blotting.
Immunohistochemistry
Intestinal samples were embedded in paraffin and sectioned at 4 µm. After
de-waxing and rehydration, endogenous peroxidase activity was quenched
(20 min, 1.5% H2O2) and antigen retrieval was performed depending on the
antibody. Paneth cells were stained with a rabbit antibody against lysozyme
(1:5000; Dako, A0099). Goblet cells were stained with Alcian Blue (pH 2.5;
Sigma) and counterstained with Nuclear Fast Red (Sigma). Other primary
antibodies were against: green fluorescent protein (1:200; Takara, 632460);
β-catenin (1:2000; Sigma, C2206); Bmi1 (1:200; Abcam, ab14389); EphB2
(1:500; R&D Systems); Myc (1:100; Santa Cruz, sc-764); Ki67 (1:500;
Novocastra, MM1); p16INK4a (1:50; Santa Cruz, sc-1207; or 1:150; Santa
Cruz, sc-1661). All primary antibodies were diluted in PBS containing
0.05% BSA and incubated overnight at 4°C, unless indicated otherwise.
Sections were then incubated with specific horseradish peroxidase (HRP)-
labeled secondary antibody, and staining was developed using
diaminobenzidine peroxidase substrate kit (Dako Cytomation). BrdU
(1:250; Abcam, ab6326) was incubated for 2 h at room temperature, and
the secondary antibody system used was a biotinylated anti-rat antibody
(Dako, E0468) incubated for 1 h at room temperature, followed by the
Vectastain ABC kit (Vector, PK6100). Staining was developed as described
above. For staining with antibodies against cleaved Notch1 (1:200; Cell
Signaling, no. 4147) and Bmi1 (Cell Signaling, no. 6964), incubations were
performed in histoblock solution (PBS 3% BSA, 20 mM MgCl2, 0.3%
Tween 20, 5% FBS), and for staining of γH2A.X (1:200; Cell Signaling, no.
2577), incubations were performed in PBS 1% normal goat serum (Dako),
0.1% surfactant-AMPS (Thermo Scientific) and 0.05% BSA. Incubations
were performed overnight at 4°C, samples were then incubated with
HRP-labeled anti-rabbit polymer (Dako Envision) and developed using
FITC-coupled Tyramide Signal Amplification System (PerkinElmer).
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